PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 6 days 23 hours 16 minutes
Making the Case for Personalized Management in mCSPC: Pertinent Characteristics to Choose the Right Therapy
Visit https://www.peervoice.com/VFH860 to view the entire programme with slides.
Managing Patients With Hemophilia A Without Inhibitors in the Era of Non-Replacement Therapy: The Experts Weigh In
Visit https://www.peervoice.com/YAM860 to view the entire programme with slides.
Defining a Patient-Centred Approach to Non-Metastatic Castration-Resistant Prostate Cancer
Visit https://www.peervoice.com/QXX860 to view the entire programme with slides.
Treatment Update in CML: What’s New, and What Does it Mean for Patients?
Treatment Update in CML: What’s New, and What Does it Mean for Patients?
Breakthroughs and Challenges With Precision Medicine: Are We Ready to Take the Leap?
Visit https://www.peervoice.com/JKU860 to view the entire programme with slides.
Case Studies in Locally Advanced and Metastatic CSCC: Integrating Immunotherapy Into Current Treatment Paradigms
Visit https://www.peervoice.com/YUE860 to view the entire programme with slides.
Hiding in Plain Sight: Identifying Patients at Risk for NASH
Hiding in Plain Sight: Identifying Patients at Risk for NASH
Putting Genomic Profiling to the Test: What Testing Method Is Best?
Putting Genomic Profiling to the Test: What Testing Method Is Best?
Practical Lessons From Real-World Evidence on CDK 4/6 Inhibitors in Metastatic Breast Cancer
Visit https://www.peervoice.com/MFJ860 to view the entire programme with slides.
Changing Strategies for Changing Times: Optimising Use of Targeted Alpha Therapies for Advanced Prostate Cancer
Visit https://www.peervoice.com/KJN860 to view the entire programme with slides.